Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review-Reference-Cited by-同舟云学术

Evaluation of fluticasone propionate/salmeterol for the treatment of COPD: a systematic review

Published:2020-04-04 Issue:6 Volume:14 Page:621-635
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Calzetta Luigino¹^ORCID,Ritondo Beatrice Ludovica¹,Matera Maria Gabriella²,Cazzola Mario¹^ORCID,Rogliani Paola¹

Affiliation:

1. Department of Experimental Medicine, University of Rome “Tor Vergata”, Rome, Italy

2. Department of Experimental Medicine, University of Campania Luigi Vanvitelli, Naples, Italy

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2020.1743180

Reference69 articles.

1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD – 2020 Report; 2020 [cited 2020 Mar 7]. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf

2. US Food and Drug Administration. ADVAIR DISKUS (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use. Reference ID: 4372031; 2000 [cited 2019 Oct 14]. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2019/021077s061lbl.pdf

3. European Medicines Agency. Seretide Diskus, EMEA/306065/2006; 2006 [cited 2019 Oct 14]. Available from: www.ema.europa.eu/en/medicines/human/referrals/seretide-diskus

4. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, and prevention of COPD – 2006 Report; 2006 [cited 2019 Oct 14]. Available from: https://www.who.int/respiratory/copd/GOLD_WR_06.pdf

5. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease—The Shifting Treatment Paradigm

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of controlled salmeterol xinafoate and fluticasone propionate release from double molecular imprinted nanoparticles;Polymer Bulletin;2024-05-14

2. Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler® Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study;Journal of Personalized Medicine;2021-11-08

3. Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study;Pulmonary Pharmacology & Therapeutics;2021-08

4. Optimizing de-escalation of inhaled corticosteroids in COPD: a systematic review of real-world findings;Expert Review of Clinical Pharmacology;2020-09-01